Joel J. Gagnier Western University, Canada, The University of Michigan, USA
Joel J. Gagnier is a Clinical Epidemiologist and Associate Professor in the Departments of Orthopedic Surgery and Epidemiology at the University of Michigan. Dr. Gagnier’s research program focuses on clinical and methodological research related to musculoskeletal conditions and clinical care. Dr. Gagnier was an assistant professor in Toronto from 2002 to 2004 and was appointed to his current position in the department of Orthopaedic Surgery and cross-appointed in the Department of Epidemiology, School of Public Health in 2010. Dr. Gagnier is a member of MICHR, IHPI, N3C (Lead of the Musculoskeletal Domain Team), CONSORT Group, the Cochrane Collaboration Musculoskeletal Group, Back Review Group, Bias Methods Group, ORS, and Editor in Chief of Research Methods in Medicine & Health Sciences (a SAGE journal). He has published over 150 peer-reviewed papers, several book chapters and given over 250 lectures and workshops at local, national and international scientific meetings. Dr. Gagnier’s research interests include: evidence-based medicine, randomized controlled trial methods and reporting, systematic review methods and reporting, health measurement scales, musculoskeletal conditions, pain and post-acute sequelae of SARS-CoV-2 infection (PASC). His current research focuses on cannabidiol (CBD) and Pain, characterizing musculoskeletal and associated health related quality of lfe outcomes in those with PASC or Long-COVID19, advancing the properties of outcome measurement scales for patients with rotator cuff injuries and those undergoing total joint arthroplasty, bias in patient reported outcomes, clinical cut points of patient reported outcomes in orthopedics, the quality and reporting of clinical research, and the efficacy of interventions for orthopaedic conditions.
